The animal medicines
sector is split on the future of the industry, according to the first
“Brexit Barometer” report released by NOAH.

While 35% of respondents are “optimistic” or “very optimistic”, 25%
are “pessimistic” and the majority – 40% – are “in the middle.”

Discuss and debate

The report was developed following the set-up of NOAH’s Brexit
Taskforce and a Brexit workshop event where NOAH members and
stakeholders, representing 16 organisations, came together to discuss
and debate the impact of the EU exit on the animal medicines sector.

The report will be repeated to track shifting sentiment as the Brexit process unfolds.

Six lenses

Attendees examined the exit from the EU and its impact on the industry through six “lenses”:

animal health and welfare

public health and food production

trade and investment

research and development, and innovation

bringing new products to market

post-licensing controls for the overall market

Animal health and welfare, and public health and food production
elicited the most positive sentiment among the group in terms of
optimism, while bringing a product to market, and trade and exports
scored lowest.